about
Genome-wide association studies identify four ER negative-specific breast cancer risk lociAssociation of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcomeGenome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer riskDIXDC1 isoform, l-DIXDC1, is a novel filamentous actin-binding proteinMutational analysis of thirty-two double-strand DNA break repair genes in breast and pancreatic cancersLarge-scale genotyping identifies 41 new loci associated with breast cancer risk.Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studiesAncestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus.Common genetic variants and modification of penetrance of BRCA2-associated breast cancerAssociation between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survivalExploring the link between MORF4L1 and risk of breast cancer.Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriersInterplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls.Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancerCommon variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2Genetic variation in mitotic regulatory pathway genes is associated with breast tumor gradeCommon non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association ConsortiumCommon breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.MicroRNA related polymorphisms and breast cancer risk.Altered expression of FANCL confers mitomycin C sensitivity in Calu-6 lung cancer cells.Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers.Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer.Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers.Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.Five polymorphisms and breast cancer risk: results from the Breast Cancer Association ConsortiumInherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general populationIdentification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer riskInherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer.Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association ConsortiumGenetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study.Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriersAssociations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers
P50
Q24622610-4F3B38B7-91DA-4A3A-898A-11830BC46BD4Q24647329-BD3BE9BF-15DB-4984-BB0C-288569B3845BQ27008356-A25CCC92-A4D0-4F18-B01E-F570D50423D3Q28249796-9CEEC0B9-4127-4E84-B35D-E7B1A0F09890Q28269064-A5BA780B-BBC5-47F7-96C4-B438E2C92533Q29416989-F98470F6-6748-40B3-ACAE-6FC01E3AA4CFQ29417100-A889AD7E-07D0-4CD9-9D0F-4C3E3678795CQ31082788-55A07788-6D3D-49CA-9951-23B2A5B1523FQ33593016-114DB0EE-D6F0-4954-8FE3-06BFD00D8204Q33641475-5F4A7D10-3246-4185-9FA8-FFD2802FD81AQ33742096-6A0C93BD-E706-4814-8762-98EEB995EA1BQ33828680-43D128EF-0DA9-4C76-91C4-0E23BBEAC03AQ33863235-0CA548F9-D7F8-4F0A-AE7D-E7396F8AD669Q33947829-F29B6413-259E-4139-BE2E-453594F491F9Q34081324-69117539-D15D-4E9C-8183-9FFE1DF7A2FFQ34123806-07762C0F-90F9-4B68-A02F-CBCE2788DDA6Q34181322-939D48B8-84FA-4221-9B29-57D73538C4CAQ34213403-C6079D93-029D-4528-858B-74A31CBCC175Q34327945-F9450E09-D5A1-43B5-94A3-023A241A5F42Q34378972-12E04E59-2982-4586-9C52-A0E399B33E85Q34379032-A1F2D71F-A012-4B62-967D-235D2B4CD79AQ34394665-CF73C57B-6169-4F25-8ABA-BA3A00E01129Q34497352-2633D585-0494-4E18-9A3D-137F4E0D70F9Q34581742-BA8511AD-D0BE-4C24-A383-48B76BBF3786Q34613604-8C8517F4-93EC-4516-8B4E-9D74238F9052Q34809698-53820BFB-2F9E-42F2-8EEF-1251CB75177BQ34949394-8C62EBEA-8D5E-4002-AFFC-00316502F4B1Q34963894-D0F9EE00-E211-46CE-8219-A35A22EDB42EQ34979715-528712DD-7B46-4A2A-BD47-AFAEBBF2FA32Q34996647-5AEA29F4-A5F3-4C66-9D33-D764A3959E2BQ35022825-459BAE80-E440-45F6-ADA1-537E7911B7F0Q35022847-6683CFA9-8FDC-4B24-B175-BBC03E4E0898Q35089479-FA0F4C53-175F-43FA-BB9C-1E565D9F5FE0Q35102646-D186CE50-6264-4F7D-8A0B-BDC53E72B95CQ35104068-8C8C97CB-C5B1-4B9A-AB7D-1FE90C2866DFQ35119701-D151B958-6AF1-4E4B-AFFA-9A67BFE7CADBQ35179897-34F01272-50A5-4231-9B62-76906A120C53Q35242849-90146BF5-DEAD-4DB1-B069-272F2949176BQ35382206-2731A86F-CA4C-4A65-B2BE-31EE073217FFQ35523236-90C5A840-4AC8-497F-B057-260FC30236DC
P50
description
forsker
@nb
researcher
@en
name
Xianshu Wang
@da
Xianshu Wang
@de
Xianshu Wang
@en
Xianshu Wang
@fr
Xianshu Wang
@nb
Xianshu Wang
@nl
Xianshu Wang
@nn
Xianshu Wang
@sv
type
label
Xianshu Wang
@da
Xianshu Wang
@de
Xianshu Wang
@en
Xianshu Wang
@fr
Xianshu Wang
@nb
Xianshu Wang
@nl
Xianshu Wang
@nn
Xianshu Wang
@sv
prefLabel
Xianshu Wang
@da
Xianshu Wang
@de
Xianshu Wang
@en
Xianshu Wang
@fr
Xianshu Wang
@nb
Xianshu Wang
@nl
Xianshu Wang
@nn
Xianshu Wang
@sv
P106
P2038
Xianshu_Wang